Skip to main content
SpringerLink
Log in

Gene Transfer and Target Diseases

  • Chapter
Non-viral Gene Therapy

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548–553

    Article  CAS  PubMed  Google Scholar 

  • Ayala G, Wheeler TM, Shalev M, Thompson TC, Miles B, Aguilar-Cordova E, Chakraborty S, Kadmon D (2000) Cytopathic effect of in situ gene therapy in prostate cancer. Hum Pathol 31:866–870

    CAS  PubMed  Google Scholar 

  • Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L (2003) Long-term stable expression of human apolipoprotein A-I mediated by helperdependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 107:2726–2732

    Article  CAS  PubMed  Google Scholar 

  • Belldegrun A, Tso CL, Zisman A, Naitoh J, Said J, Pantuck AJ, Hinkel A, deKernion J, Figlin R (2001) Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology. Hum Gene Ther 12:883–892

    Article  CAS  PubMed  Google Scholar 

  • Benoit P, Emmanuel F, Caillaud JM, Bassinet L, Castro G, Gallix P, Fruchart JC, Branellec D, Denefle P, Duverger N (1999) Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models. Circulation 99:105–110

    CAS  PubMed  Google Scholar 

  • Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC (1993) p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 53:3369–3373

    CAS  PubMed  Google Scholar 

  • Brieger J, Bedavanija A, Lehr HA, Maurer J, Mann WJ (2003) Expression of angiogenic growth factors in acoustic neurinoma. Acta Otolaryngol 123:1040–1045

    Article  PubMed  Google Scholar 

  • Brousseau ME, Wang J, Demosky SJ, Jr., Vaisman BL, Talley GD, Santamarina-Fojo S, Brewer HB, Jr., Hoeg JM (1998) Correction of hypoalphalipoproteinemia in LDL receptordeficient rabbits by lecithin: cholesterol acyltransferase. J Lipid Res 39:1558–1567

    CAS  PubMed  Google Scholar 

  • Burgess TL, Fisher EF, Ross SL, Bready JV, Qian YX, Bayewitch LA, Cohen AM, Herrera CJ, Hu SS, Kramer TB (1995) The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci U S A 92:4051–4055

    CAS  PubMed  Google Scholar 

  • Champion HC, Bivalacqua TJ, D’Souza FM, Ortiz LA, Jeter JR, Toyoda K, Heistad DD, Hyman AL, Kadowitz PJ (1999) Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses. Circ Res 84:1422–1432

    CAS  PubMed  Google Scholar 

  • Champion HC, Bivalacqua TJ, Toyoda K, Heistad DD, Hyman AL, Kadowitz PJ (2000) In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation 101:923–930

    CAS  PubMed  Google Scholar 

  • Chang MW, Barr E, Lu MM, Barton K, Leiden JM (1995a) Adenovirus-mediated overexpression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 96:2260–2268

    CAS  PubMed  Google Scholar 

  • Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM (1995b) Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267:518–522

    CAS  PubMed  Google Scholar 

  • Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE (1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327:70–75

    CAS  PubMed  Google Scholar 

  • Cioffi L, Sturtz FG, Wittmer S, Barut B, Smith-Gbur J, Moore V, Zupancic T, Gilligan B, Auerbach R, Gomez F, Chauvin F, Antczak M, Platika D, Snodgrass HR (1999) A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E. Gene Ther 6:1153–1159

    Article  CAS  PubMed  Google Scholar 

  • Claesson-Welsh L (2003) Signal transduction by vascular endothelial growth factor receptors. Biochem Soc Trans 31:20–24

    CAS  PubMed  Google Scholar 

  • Demers GW, Harris MP, Wen SF, Engler H, Nielsen LL, Maneval DC (1998) A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth. Cancer Gene Ther 5:207–214

    CAS  PubMed  Google Scholar 

  • Dichek DA, Anderson J, Kelly AB, Hanson SR, Harker LA (1996) Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 93:301–309

    CAS  PubMed  Google Scholar 

  • Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039

    CAS  PubMed  Google Scholar 

  • Edvinsson L, Ekman R, Jansen I, McCulloch J, Mortensen A, Uddman R (1991) Reduced levels of calcitonin gene-related peptide-like immunoreactivity in human brain vessels after subarachnoid haemorrhage. Neurosci Lett 121:151–154

    Article  CAS  PubMed  Google Scholar 

  • Excoffon KJ, Liu G, Miao L, Wilson JE, McManus BM, Semenkovich CF, Coleman T, Benoit P, Duverger N, Branellec D, Denefle P, Hayden MR, Lewis ME (1997) Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase-deficient mice by adenovirus-mediated expression of human lipoprotein lipase. Arterioscler Thromb Vasc Biol 17:2532–2539

    CAS  PubMed  Google Scholar 

  • Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527–543

    Article  CAS  PubMed  Google Scholar 

  • Ferrara N (2000) VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11:617–624

    Article  CAS  PubMed  Google Scholar 

  • Ferrara N (2001) Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280:C1358–C1366

    CAS  PubMed  Google Scholar 

  • Galzie Z, Kinsella AR, Smith JA (1997) Fibroblast growth factors and their receptors. Biochem Cell Biol 75:669–685

    Article  CAS  PubMed  Google Scholar 

  • Goldstein JL HH, Brown MS (2001) Familial hypercholesterolemia. Vol chap. 120. McGraw-Hill, New York

    Google Scholar 

  • Gough PJ, Raines EW (2003) Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector. Blood 101:485–491

    Article  CAS  PubMed  Google Scholar 

  • Greeve J, Jona VK, Chowdhury NR, Horwitz MS, Chowdhury JR (1996) Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits. J Lipid Res 37:2001–2017

    CAS  PubMed  Google Scholar 

  • Griffith TS, Broghammer EL (2001) Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus. Mol Ther 4:257–266

    Article  CAS  PubMed  Google Scholar 

  • Grines C, Rubanyi GM, Kleiman NS, Marrott P, Watkins MW (2003) Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. Am J Cardiol 92:24N–31N

    Article  CAS  PubMed  Google Scholar 

  • Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ, 3rd, Stein EA, Lupien PJ, Brewer HB, Jr., Raper SE (1995) A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1:1148–1154

    Article  CAS  PubMed  Google Scholar 

  • Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ, Wilson JM (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 6:335–341

    Article  CAS  PubMed  Google Scholar 

  • Hall SJ, Mutchnik SE, Yang G, Timme TL, Nasu Y, Bangma CH, Woo SL, Shaker M, Thompson TC (1999) Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer. Cancer Gene Ther 6:54–63

    Article  CAS  PubMed  Google Scholar 

  • Harris JD, Schepelmann S, Athanasopoulos T, Graham IR, Stannard AK, Mohri Z, Hill V, Hassall DG, Owen JS, Dickson G (2002) Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E. Gene Ther 9:21–29

    Article  CAS  PubMed  Google Scholar 

  • Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193:1005–1014

    Article  CAS  PubMed  Google Scholar 

  • Hayashi S, Morishita R, Nakamura S, Yamamoto K, Moriguchi A, Nagano T, Taiji M, Noguchi H, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1999) Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. Circulation 100:II301–II308

    CAS  PubMed  Google Scholar 

  • Hedlund TE, Duke RC, Schleicher MS, Miller GJ (1998) Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 36:92–101

    Article  CAS  PubMed  Google Scholar 

  • Hedlund TE, Meech SJ, Srikanth S, Kraft AS, Miller GJ, Schaack JB, Duke RC (1999) Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells. Cell Death Differ 6:175–182

    Article  CAS  PubMed  Google Scholar 

  • Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT, Laukkanen J, Niemi M, Kossila M, Hakkinen TP, Kivela A, Enholm B, Mansukoski H, Turunen AM, Alitalo K, Yla-Herttuala S (2000) Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102:2262–2268

    CAS  PubMed  Google Scholar 

  • Horio Y, Hasegawa Y, Sekido Y, Takahashi M, Roth JA, Shimokata K (2000) Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells. Cancer Gene Ther 7:537–544

    Article  CAS  PubMed  Google Scholar 

  • Hull GW, McCurdy MA, Nasu Y, Bangma CH, Yang G, Shimura S, Lee HM, Wang J, Albani J, Ebara S, Sato T, Timme TL, Thompson TC (2000) Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines. Clin Cancer Res 6:4101–4109

    CAS  PubMed  Google Scholar 

  • Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo E, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli G (1995) Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med 1:541–545

    Article  CAS  PubMed  Google Scholar 

  • Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD, Ewing CM (1995) Molecular biology of prostate cancer progression. Cancer Surv 23:19–32

    CAS  PubMed  Google Scholar 

  • Jalkanen J, Leppanen P, Narvanen O, Greaves DR, Yla-Herttuala S (2003a) Adenovirusmediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice. Atherosclerosis 169:95–103

    Article  CAS  PubMed  Google Scholar 

  • Jalkanen J, Leppanen P, Pajusola K, Narvanen O, Mahonen A, Vahakangas E, Greaves DR, Bueler H, Yla-Herttuala S (2003b) Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice. Mol Ther 8:903–910

    Article  CAS  PubMed  Google Scholar 

  • Jarrard DF, Bova GS, Ewing CM, Pin SS, Nguyen SH, Baylin SB, Cairns P, Sidransky D, Herman JG, Isaacs WB (1997) Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosomes Cancer 19:90–96

    Article  CAS  PubMed  Google Scholar 

  • Javerzat S, Auguste P, Bikfalvi A (2002) The role of fibroblast growth factors in vascular development. Trends Mol Med 8:483–489

    Article  CAS  PubMed  Google Scholar 

  • Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 15:290–298

    CAS  PubMed  Google Scholar 

  • Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T (1999) Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 30:867–871; discussion 872

    CAS  PubMed  Google Scholar 

  • Kankkonen HM, Vahakangas E, Marr RA, Pakkanen T, Laurema A, Leppanen P, Jalkanen J, Verma IM, Yla-Herttuala S (2004) Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy. Mol Ther 9:548–556

    Article  CAS  PubMed  Google Scholar 

  • Kawakita M, Rao GS, Ritchey JK, Ornstein DK, Hudson MA, Tartaglia J, Paoletti E, Humphrey PA, Harmon TJ, Ratliff TL (1997) Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth. J Natl Cancer Inst 89:428–436

    Article  CAS  PubMed  Google Scholar 

  • Kiba A, Sagara H, Hara T, Shibuya M (2003) VEGFR-2-specific ligand VEGF-E induces nonedematous hyper-vascularization in mice. Biochem Biophys Res Commun 301:371–377

    Article  CAS  PubMed  Google Scholar 

  • Koeneman KS, Kao C, Ko SC, Yang L, Wada Y, Kallmes DF, Gillenwater JY, Zhau HE, Chung LW, Gardner TA (2000) Osteocalcin-directed gene therapy for prostate-cancer bone metastasis. World J Urol 18:102–110

    Article  CAS  PubMed  Google Scholar 

  • Koike T, Liang J, Wang X, Ichikawa T, Shiomi M, Liu G, Sun H, Kitajima S, Morimoto M, Watanabe T, Yamada N, Fan J (2004) Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. J Biol Chem 279:7521–7529

    Article  CAS  PubMed  Google Scholar 

  • Konishi N, Cho M, Yamamoto K, Hiasa Y (1997) Genetic changes in prostate cancer. Pathol Int 47:735–747

    CAS  PubMed  Google Scholar 

  • Kozarsky KF, Bonen DK, Giannoni F, Funahashi T, Wilson JM, Davidson NO (1996) Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum Gene Ther 7:943–957

    CAS  PubMed  Google Scholar 

  • Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM (1994) In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 269:13695–13702

    CAS  PubMed  Google Scholar 

  • Laitinen M, Zachary I, Breier G, Pakkanen T, Hakkinen T, Luoma J, Abedi H, Risau W, Soma M, Laakso M, Martin JF, Yla-Herttuala S (1997) VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 8:1737–1744

    CAS  PubMed  Google Scholar 

  • Lebherz C, Gao G, Louboutin JP, Millar J, Rader D, Wilson JM (2004) Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia. J Gene Med 6:663–672

    Article  CAS  PubMed  Google Scholar 

  • Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309

    CAS  PubMed  Google Scholar 

  • Levy AP, Levy NS, Wegner S, Goldberg MA (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333–13340

    CAS  PubMed  Google Scholar 

  • Liu G, Ashbourne Excoffon KJ, Wilson JE, McManus BM, Rogers QR, Miao L, Kastelein JJ, Lewis ME, Hayden MR (2000) Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer. Hum Gene Ther 11:21–32

    Article  CAS  PubMed  Google Scholar 

  • Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM (1998) Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800–2804

    CAS  PubMed  Google Scholar 

  • Lu S, Tsai SY, Tsai MJ (1997) Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res 57:4511–4516

    CAS  PubMed  Google Scholar 

  • Maggard M, Meng L, Ke B, Allen R, Devgan L, Imagawa DK (2001) Antisense TGF-beta2 immunotherapy for hepatocellular carcinoma: treatment in a rat tumor model. Ann Surg Oncol 8:32–37

    CAS  PubMed  Google Scholar 

  • Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vecchio S, Lei KJ, Chou JY, Persico MG (1993) Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8:925–931

    CAS  PubMed  Google Scholar 

  • Martiniello-Wilks R, Garcia-Aragon J, Daja MM, Russell P, Both GW, Molloy PL, Lockett LJ, Russell PJ (1998) In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors. Hum Gene Ther 9:1617–1626

    CAS  PubMed  Google Scholar 

  • McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS (2002) Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 33:2317–2323

    CAS  PubMed  Google Scholar 

  • Moody DB, Robinson JC, Ewing CM, Lazenby AJ, Isaacs WB (1994) Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo. Prostate 24:244–251

    CAS  PubMed  Google Scholar 

  • Morishige K, Shimokawa H, Yamawaki T, Miyata K, Eto Y, Kandabashi T, Yogo K, Higo T, Egashira K, Ueno H, Takeshita A (2000) Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J Am Coll Cardiol 35:1040–1047

    Article  CAS  PubMed  Google Scholar 

  • Morishita R (2004) Perspective in progress of cardiovascular gene therapy. J Pharmacol Sci 95:1–8

    Article  CAS  PubMed  Google Scholar 

  • Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ (1993) Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A 90:8474–8478

    CAS  PubMed  Google Scholar 

  • Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1999) Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33:1379–1384

    CAS  PubMed  Google Scholar 

  • Morishita R, Sakaki M, Yamamoto K, Iguchi S, Aoki M, Yamasaki K, Matsumoto K, Nakamura T, Lawn R, Ogihara T, Kaneda Y (2002) Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene. Circulation 105:1491–1496

    Article  CAS  PubMed  Google Scholar 

  • Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T (1997) In vivo transfection of cis element “decoy” against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 3:894–899

    Article  CAS  PubMed  Google Scholar 

  • Nagaya N (2004) Drug therapy of primary pulmonary hypertension. Am J Cardiovasc Drugs 4:75–85

    Article  CAS  PubMed  Google Scholar 

  • Nagaya N, Yokoyama C, Kyotani S, Shimonishi M, Morishita R, Uematsu M, Nishikimi T, Nakanishi N, Ogihara T, Yamagishi M, Miyatake K, Kaneda Y, Tanabe T (2000) Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats. Circulation 102:2005–2010

    CAS  PubMed  Google Scholar 

  • Nasu Y, Bangma CH, Hull GW, Lee HM, Hu J, Wang J, McCurdy MA, Shimura S, Yang G, Timme TL, Thompson TC (1999) Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther 6:338–349

    Article  CAS  PubMed  Google Scholar 

  • Nishida T, Ueno H, Atsuchi N, Kawano R, Asada Y, Nakahara Y, Kamikubo Y, Takeshita A, Yasui H (1999) Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit. Circ Res 84:1446–1452

    CAS  PubMed  Google Scholar 

  • Nozaki K, Kikuchi H, Mizuno N (1989) Changes of calcitonin gene-related peptide-like immunoreactivity in cerebrovascular nerve fibers in the dog after experimentally produced subarachnoid hemorrhage. Neurosci Lett 102:27–32

    Article  CAS  PubMed  Google Scholar 

  • Ogawa S, Oku A, Sawano A, Yamaguchi S, Yazaki Y, Shibuya M (1998) A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem 273:31273–31282

    CAS  PubMed  Google Scholar 

  • Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767–2770

    Article  CAS  PubMed  Google Scholar 

  • Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 93:2576–2581

    Article  CAS  PubMed  Google Scholar 

  • Onoda K, Ono S, Ogihara K, Shiota T, Asari S, Ohmoto T, Ninomiya Y (1996) Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 85:846–852

    CAS  PubMed  Google Scholar 

  • Onoue H, Tsutsui M, Smith L, Stelter A, O’Brien T, Katusic ZS (1998) Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29:1959–1965; discussion 1965–1966

    CAS  PubMed  Google Scholar 

  • Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M (1996) Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292–15297

    CAS  PubMed  Google Scholar 

  • Pakkanen TM, Laitinen M, Hippelainen M, Kallionpaa H, Lehtolainen P, Leppanen P, Luoma JS, Tarvainen R, Alhava E, Yla-Herttuala S (1999) Enhanced plasma cholesterol lowering effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and stimulation of hepatocyte proliferation by combined partial liver resection and thymidine kinase-ganciclovir treatment. Gene Ther 6:34–41

    Article  CAS  PubMed  Google Scholar 

  • Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH (1998) Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med 4:222–227

    Article  CAS  PubMed  Google Scholar 

  • Rade JJ, Schulick AH, Virmani R, Dichek DA (1996) Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat Med 2:293–298

    Article  CAS  PubMed  Google Scholar 

  • Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholova I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Yla-Herttuala S (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 92:1098–1106

    Article  CAS  PubMed  Google Scholar 

  • Roylance R, Spurr N, Sheer D (1997) The genetic analysis of prostate carcinoma. Semin Cancer Biol 8:37–44

    Article  CAS  PubMed  Google Scholar 

  • Sanford MA, Yan Y, Canfield SE, Hassan W, Selleck WA, Atkinson G, Chen SH, Hall SJ (2001) Independent contributions of GR-1+ leukocytes and Fas/FasL interactions to induce apoptosis following interleukin-12 gene therapy in a metastatic model of prostate cancer. Hum Gene Ther 12:1485–1498

    Article  CAS  PubMed  Google Scholar 

  • Seguret-Mace S, Latta-Mahieu M, Castro G, Luc G, Fruchart JC, Rubin E, Denefle P, Duverger N (1996) Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene. Circulation 94:2177–2184

    CAS  PubMed  Google Scholar 

  • Shalev M, Kadmon D, Teh BS, Butler EB, Aguilar-Cordova E, Thompson TC, Herman JR, Adler HL, Scardino PT, Miles BJ (2000) Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer. J Urol 163:1747–1750

    Article  CAS  PubMed  Google Scholar 

  • Siddiqui AJ, Blomberg P, Wardell E, Hellgren I, Eskandarpour M, Islam KB, Sylven C (2003) Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 310:1002–1009

    Article  CAS  PubMed  Google Scholar 

  • Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Lim M, Weber CE, Baccala AA, Goemann MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF, Nelson WG (1999) Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colonystimulating factor using ex vivo gene transfer. Cancer Res 59:5160–5168

    CAS  PubMed  Google Scholar 

  • Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu JF, Pastore C, Mahfoudi A, Denefle P, Isner JM, Walsh K (1997) p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev 11:1674–1689

    CAS  PubMed  Google Scholar 

  • Steiner MS, Anthony CT, Lu Y, Holt JT (1998) Antisense c-myc retroviral vector suppresses established human prostate cancer. Hum Gene Ther 9:747–755

    CAS  PubMed  Google Scholar 

  • Suzuki J, Isobe M, Morishita R, Aoki M, Horie S, Okubo Y, Kaneda Y, Sawa Y, Matsuda H, Ogihara T, Sekiguchi M (1997) Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide. Nat Med 3:900–903

    Article  CAS  PubMed  Google Scholar 

  • Tang NH, Chen YL, Wang XQ, Li XJ, Yin FZ, Wang XZ (2004) Cooperative inhibitory effects of antisense oligonucleotide of cell adhesion molecules and cimetidine on cancer cell adhesion. World J Gastroenterol 10:62–66

    CAS  PubMed  Google Scholar 

  • Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG (1998) Expression of cyclindependent kinase inhibitors in vascular disease. Circ Res 82:396–403

    CAS  PubMed  Google Scholar 

  • Toloza EM, Hunt K, Swisher S, McBride W, Lau R, Pang S, Rhoades K, Drake T, Belldegrun A, Glaspy J, Economou JS (1996) In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther 3:11–17

    CAS  PubMed  Google Scholar 

  • Topol EJ, Serruys PW (1998) Frontiers in interventional cardiology. Circulation 98:1802–1820

    CAS  PubMed  Google Scholar 

  • Toyoda K, Chu Y, Heistad DD (2003) Gene therapy for cerebral vascular disease: update 2003. Br J Pharmacol 139:1–9

    Article  CAS  PubMed  Google Scholar 

  • Trojan J, Johnson TR, Rudin SD, Blossey BK, Kelley KM, Shevelev A, Abdul-Karim FW, Anthony DD, Tykocinski ML, Ilan J (1994) Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci U S A 91:6088–6092

    CAS  PubMed  Google Scholar 

  • Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, Voelkel NF (1999) Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 159:1925–1932

    CAS  PubMed  Google Scholar 

  • Ueno H, Haruno A, Morisaki N, Furuya M, Kangawa K, Takeshita A, Saito Y (1997a) Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation 96:2272–2279

    CAS  PubMed  Google Scholar 

  • Ueno H, Li JJ, Masuda S, Qi Z, Yamamoto H, Takeshita A (1997b) Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 17:2453–2460

    CAS  PubMed  Google Scholar 

  • Vale PR, Losordo DW, Milliken CE, Maysky M, Esakof DD, Symes JF, Isner JM (2000) Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 102:965–974

    CAS  PubMed  Google Scholar 

  • Voelkel-Johnson C, King DL, Norris JS (2002) Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Cancer Gene Ther 9:164–172

    Article  CAS  PubMed  Google Scholar 

  • von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ (1995) Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92:1137–1141

    PubMed  Google Scholar 

  • Ward NL, Dumont DJ (2002) The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 13:19–27

    Article  CAS  PubMed  Google Scholar 

  • Waugh JM, Yuksel E, Li J, Kuo MD, Kattash M, Saxena R, Geske R, Thung SN, Shenaq SM, Woo SL (1999) Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circ Res 84:84–92

    CAS  PubMed  Google Scholar 

  • Yamauchi A, Ito Y, Morikawa M, Kobune M, Huang J, Sasaki K, Takahashi K, Nakamura K, Dehari H, Niitsu Y, Abe T, Hamada H (2003) Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med 5:994–1004

    Article  CAS  PubMed  Google Scholar 

  • Yan ZQ, Yokota T, Zhang W, Hansson GK (1996) Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res 79:38–44

    CAS  PubMed  Google Scholar 

  • Yen N, Ioannides CG, Xu K, Swisher SG, Lawrence DD, Kemp BL, El-Naggar AK, et al. (2000) Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53). Cancer Gene Ther 7:530–536

    Article  CAS  PubMed  Google Scholar 

  • Yonemitsu Y, Kaneda Y, Tanaka S, Nakashima Y, Komori K, Sugimachi K, Sueishi K (1998) Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 82:147–156

    CAS  PubMed  Google Scholar 

  • Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW (2003) VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 111:717–725

    Article  CAS  PubMed  Google Scholar 

  • Zoldhelyi P, Chen ZQ, Shelat HS, McNatt JM, Willerson JT (2001) Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci USA 98:4078–4083

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bioscience, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka, 565-8565, Japan

    Mariko Harada-Shiba

Authors
  1. Mariko Harada-Shiba
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan

    Kazunari Taira Ph.D

  2. Gene Function Research Center, National Institute of Advanced Industrial Science and Technology (AIST), Central 4, 1-1-1 Higashi, Tsukuba Science City, 305-8562, Japan

    Kazunari Taira Ph.D

  3. Department of Materials Science and Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan

    Kazunori Kataoka Ph.D

  4. Department of Applied Chemistry, Faculty of Engineering, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581, Japan

    Takuro Niidome Ph.D

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Harada-Shiba, M. (2005). Gene Transfer and Target Diseases. In: Taira, K., Kataoka, K., Niidome, T. (eds) Non-viral Gene Therapy. Springer, Tokyo. https://doi.org/10.1007/4-431-27879-6_20

Download citation

Publish with us

Policies and ethics

Search

Navigation